Cardiogenic Shock in a Hemodialyzed Patient on Flecainide: Treatment with Intravenous Fat Emulsion, Extracorporeal Cardiac Life Support, and CytoSorb® Hemoadsorption

A 67-year-old woman with a history of end-stage renal disease on hemodialysis received a therapeutic dose (150 mg daily) of flecainide for three weeks. She was admitted to the Emergency Department for malaise and dizziness, and the electrocardiogram revealed ventricular tachycardia treated by amioda...

Descripción completa

Detalles Bibliográficos
Autores principales: De Schryver, Nicolas, Hantson, Philippe, Haufroid, Vincent, Dechamps, Mélanie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2019
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6681578/
https://www.ncbi.nlm.nih.gov/pubmed/31428479
http://dx.doi.org/10.1155/2019/1905871

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6681578/
https://www.ncbi.nlm.nih.gov/pubmed/31428479
http://dx.doi.org/10.1155/2019/1905871

Ejemplares similares